Trials / Completed
CompletedNCT04510337
Does Adding Magnesium Sulphate to Low Dose Rocuronium Affects Depth of Blockade
Does Adding Magnesium Sulphate to Low Dose Rocuronium Affects the Depth of Blockade in Cancer Patients Undergoing Direct Laryngoscope Surgical Procedures
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- National Cancer Institute, Egypt · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study aim is to compare the effect of magnesium sulphate combined with low dose rocuronium versus standard dose rocuronium
Detailed description
Comparing the effect of magnesium sulphate combined to low dose rocuronium versus standard dose rocuronium in cancer patients undergoing direct laryngoscopy for laryngeal tumors regarding intubating conditions, intraoperative relaxation, depth of anesthesia and recovery time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | standard rocuronium dose | 0.6 mg/kg rocuronium during induction of anesthesia |
| DRUG | Magnesium sulfate | 50 mg/kg magnesium sulphate added to 0.40 mg/kg rocuronium |
Timeline
- Start date
- 2018-04-02
- Primary completion
- 2021-02-20
- Completion
- 2021-02-20
- First posted
- 2020-08-12
- Last updated
- 2021-03-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04510337. Inclusion in this directory is not an endorsement.